Evidence map›Paper›PMID 42015137›Full record

ArticleBMC nephrology2026

A causal link or coincidence? Anti-nephrin antibody-positive minimal change disease coexisting with neuroblastoma in a child.

Han Li, Sanlong Zhao, Ruochen Che

Abstract readCase Reports
In one paragraph

Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Han LiDepartment of Emergency/Critical Medicine, Children's Hospital of Nanjing Medical University, 72 Guangzhou Road, Nanjing, Jiangsu Province, 210008, China.
Sanlong Zhao *Department of Nephrology, Children's Hospital of Nanjing Medical University, 72 Guangzhou Road, Nanjing, Jiangsu Province, 210008, China. slzhao1981@163.com.
Ruochen Che *Department of Nephrology, Children's Hospital of Nanjing Medical University, 72 Guangzhou Road, Nanjing, Jiangsu Province, 210008, China. cheruochen@njmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe combination of minimal change disease and solid tumors is uncommon, and its mechanism is often associated with immune disorders or metabolic abnormalities. CASE PRESENTATION: Here, we describe an 8-year-old girl who presented with nephrotic syndrome characterized by edema and proteinuria as the initial symptoms. Chest imaging incidentally revealed the presence of a chest mass. Subsequently, a PET/CT scan ruled out the possibility of renal infiltration. Following surgical resection of the mass, pathological examination ultimately confirmed it as neuroblastoma. However, even after complete tumor resection, the nephrotic syndrome in the child did not show any relief. A kidney biopsy confirmed minimal change disease, and serum anti-nephrin antibodies were detected. After treatment with glucocorticoids, significant relief of edema, proteinuria, and hypoalbuminemia was observed in the short term.

conclusionWe report a case of newly diagnosed MCD associated with neuroblastoma. This rare case highlights the importance of integrating clinical manifestations, imaging, pathology, and anti-nephrin antibody testing to assist in diagnosis and treatment.

Indexed as

AutoantibodiesMembrane ProteinsNephrosis, LipoidNeuroblastomaChildFemaleHumansAutoantibodiesMembrane ProteinsnephrinAnti-nephrin antibodyCase reportMinimal change diseaseNeuroblastomaPediatric case

Identifiers

PMID42015137
PMCPMC13238098

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.